Primary Job Title CEO Primary Organization 
Cytox
Location Hemel Hempstead, Hertford, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Dr Richard Pither is CEO of Cytox Ltd. Richard has been involved in the development diagnostic and therapeutic pharmaceutical products for more than twenty years.
He has held senior R&D and leadership positions in global Pharmaceutical companies including GE Healthcare (Medical Diagnostics), UCB-Celltech, Lorantis and Amersham plc. During
this time, he was involved in the development of a novel 18F-PET radiopharmaceutical for imaging amyloid deposition in the brains of Alzheimer’s Disease patients for more than ten years.
Richard has a BSc in Cellular and Molecular Pathology from Bristol University. His PhD, also at Bristol, was gained in the field of immunology and vaccine design, followed by post-doctoral research at Harvard.
